PH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications
Overview
Affiliations
Smart nano-carriers have attained great significance in the biomedical field due to their versatile and interesting designs with different functionalities. The initial stages of the development of nanocarriers mainly focused on the guest loading efficiency, biocompatibility of the host and the circulation time. Later the requirements of less side effects with more efficacy arose by attributing targetability and stimuli-responsive characteristics to nano-carriers along with their bio- compatibility. Researchers are utilizing many stimuli-responsive polymers for the better release of the guest molecules at the targeted sites. Among these, pH-triggered release achieves increasing importance because of the pH variation in different organ and cancer cells of acidic pH. This specific feature is utilized to release the guest molecules more precisely in the targeted site by designing polymers having specific functionality with the pH dependent morphology change characteristics. In this review, we mainly concert on the pH-responsive polypeptides and some interesting nano-carrier designs for the effective theranostic applications. Also, emphasis is made on pharmaceutical application of the different nano-carriers with respect to the organ, tissue and cellular level pH environment.
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.
Gabellone S, Vanni S, Fausti V, Miserocchi G, Liverani C, Spadazzi C Heliyon. 2024; 10(23):e40596.
PMID: 39687122 PMC: 11647801. DOI: 10.1016/j.heliyon.2024.e40596.
Nucleic acid drugs: recent progress and future perspectives.
Sun X, Setrerrahmane S, Li C, Hu J, Xu H Signal Transduct Target Ther. 2024; 9(1):316.
PMID: 39609384 PMC: 11604671. DOI: 10.1038/s41392-024-02035-4.
Biomaterials for Cell Manufacturing.
Miller R, Temenoff J ACS Macro Lett. 2024; 13(11):1521-1530.
PMID: 39466845 PMC: 11580378. DOI: 10.1021/acsmacrolett.4c00634.
Advances in peptide-based drug delivery systems.
Guo S, Wang J, Wang Q, Wang J, Qin S, Li W Heliyon. 2024; 10(4):e26009.
PMID: 38404797 PMC: 10884816. DOI: 10.1016/j.heliyon.2024.e26009.
Jin Z, Al Amili M, Guo S Biomedicines. 2024; 12(2).
PMID: 38398021 PMC: 10886702. DOI: 10.3390/biomedicines12020417.